Retroperitoneal fibromatosis-associated herpesvirus of rhesus macaques (RFHVMm) is a gammaherpesvirus closely related to human herpesvirus-8 (HHV-8), which is thought to be a necessary cofactor for the development of Kaposi's sarcoma (KS) in humans. Here, RFHVMm infection of rhesus macaques exposed to the D-type retrovirus simian retrovirus-2 (SRV-2) is described. Development of SRV-2 viraemia, infection with simian immunodeficiency virus or administration of cyclosporin A could result in persistent RFHVMm viraemia. From this, it is concluded that productive retrovirus infection or otherwise-induced immune suppression has the ability to activate this herpesvirus in vivo. Elevated levels of circulating interleukin-6, a cytokine that plays a central role in KS, were found in RFHVMm-viraemic animals. In viraemic animals, RFHVMm was found in tissues that are common sites for the development of AIDS-associated KS, especially the oral cavity. Together, these data suggest a common biology between RFHVMm infection of macaques and HHV-8 infection and pathogenesis in humans.
Introduction
We have recently described sequence fragments indicative of a new subgroup of gammaherpesviruses related to human herpesvirus-8 (HHV-8), the virus associated with Kaposi's sarcoma (KS). These sequences were detected in sections of macaque retroperitoneal fibromatosis (RF) tissue and the viruses were tentatively named RF-associated herpesvirus (RFHV). Two variants of RFHV were found and these variants are described with a suffix, indicating the species in which they were first detected. We thus distinguish RFHVMn, the variant identified in tissues of Macaca nemestrina (pigtailed macaque), and RFHVMm, the variant found in an RF tissue sample from M. mulatta (rhesus macaque). Limited disease-association studies indicated the presence of RFHVMn sequences in 35 % of RF tissue samples and in none of more than 30 tissues from four M. nemestrina that did not have RF (Rose et al., 1997) .
RF can occur both in a localized form and in a progressive form that grows rapidly to fill the abdominal cavity and encase the intestines and associated organs. In proliferative lesions, the appearance of spindle-shaped cells and lymphocytic infiltrates and the formation of new blood vessels is reminiscent of human KS . The cells in proliferative lesions stain positively for factor VIII, as well as for α-actin, vimentin and desmin, indicating a likely origin as pericytes or vascular smooth muscle cells (Tsai et al., 1990 (Tsai et al., , 1995 , whereas in the sclerotic form of the lesion (often associated with the progressive form), fibroblasts appear to be the major cell type involved . In human KS, the major cell types (spindle cells) also stain positively for vimentin and α-actin but are negative for desmin, which indicates that although KS and RF cells share a common origin as mesenchymal cells, they are not completely homologous (Massarelli et al., 1989) . The similarities to human KS are even more striking when the phylogeny of the associated viruses is taken into account, in that of all the gammaherpesviruses RFHV is most closely related to HHV-8 (Rose et al., 1997) . This association of similar tumours with similar viruses indicates a common aetiology for these diseases. Evidence for HHV-8 being a necessary factor in KS aetiology is mounting, based on the strong association of HHV-8 with epidemic, classical and endemic KS (Chang et al., 1994 ; Dupin et al., 1995 ; Huang et al., 1995 ; Moore & Chang, 1995) as well as on recent molecular and serological data indicating that reactivity to HHV-8 antigens or nucleic acid sequences predicts development of KS (Simpson et al., 1996 ; Whitby et al., 1995) . Induction of RF through RFHV infection of macaques would provide an experimental infection model in which the role of herpesviruses such as RFHV and HHV-8 could be investigated.
RF is a uniformly fatal disease in macaques, and was epidemic, primarily in the Washington Regional Primate Research Center (WaRPRC) and the Oregon Regional Primate Research Center (ORPRC), with the first case occurring in Washington in 1976 and the epidemic ending in the late 1980s. After 1990, RF was only seen sporadically, both at the WaRPRC and elsewhere. At the height of the epidemic (1977) (1978) (1979) (1980) (1981) (1982) (1983) , the incidence of RF in colony-born M. nemestrina was 5n7 % for animals between 1 and 2 years of age, and 82 animals of different macaque species, primarily M. nemestrina, were affected during those years . The sudden onset of the epidemic indicated the involvement of a newly introduced infectious agent as a necessary (co)factor in the development of RF. This theory was supported by the fact that experimental inoculations of macaques with suspensions of RF tissue resulted in the induction of RF in three of 16 animals . Subsequent research showed a strong association between RF and infection with a D-type retrovirus, simian retrovirus-2 (SRV-2) (Benveniste et al., 1986 ; Shiigi et al., 1986 ; Stromberg et al., 1984) . SRV-2 can be suppressed efficiently by the host's immune system, as indicated by a balance between viraemia and antibody status. All animals with RF that were assayed for SRV-2 were found to be viraemic and SRV-2 could be isolated from 12 of 12 RF samples (Benveniste et al., 1986) . Experimental infections with SRV-2 yielded RF in one of six animals inoculated. This animal was one of two among the six that did not develop antibodies to SRV-2 ; the other died with early potential manifestations of RF, including capsular fibrosis of the mesenteric lymph nodes (LNs) (Benveniste et al., 1986) .
The necessity of SRV-2 infection as a (co)factor for the development of RF would explain the infectious nature of the disease. Widespread screening of macaques before introduction into monkey colonies has revealed that the prevalence of SRV-2 in wild-caught animals is high (Pamungkas et al., 1992 ; D. Iskandriati, personal communication) . These data suggest that SRV-2 infection could already have been present in the WaRPRC colony before 1976 and, in that case, SRV-2 infection would not have been the cause of the sudden appearance of RF in that year. Unfortunately, retrospective serological data to confirm this suggestion are lacking. If SRV-2 prevalence was indeed high in the WaRPRC before 1976, the sudden appearance of this disease could be due to the introduction of yet another agent into the colony at that time. Our discovery of RFHV in association with RF supports this theory.
In order to understand the potential role of RFHV in the induction of RF, it is important to have information about the natural history of RFHV infection of macaques, as well as about the general prevalence of RFHV in captive monkey populations. If, like most herpesviruses, RFHV has a high prevalence, it is important to understand what factors distinguish between the natural, non-pathogenic state and RF. In order to begin to clarify some of these issues, we have made an attempt to transfer RFHVMm into rhesus macaques. We chose this system because the only potential source of RFHV that we could locate at the beginning of this study was a frozen piece of an RF tumour from a rhesus macaque. Our results indicate that this transfer was not successful but that the macaques were already infected with RFHVMm. This allowed us to study the reactivation of RFHVMm infection in rhesus macaques.
Methods
Monkeys. Six rhesus macaques were obtained from the ORPRC. Table 1 lists their age and body weight at the time of entry into the WaRPRC. After inoculation, the animals' complete blood cell counts and lymphocyte subsets (CD4, CD8, CD19) were followed at 1 week intervals for the first 8 weeks and at biweekly and monthly intervals thereafter. All animals (including controls) were housed at the WaRPRC in accordance with the American Association for Accreditation of Laboratory Animal Care. Procedures involving macaques in this study were pre-authorized by the University of Washington Animal Care and Use Committee. Monitoring of and invasive procedures on the macaques, including intravenous injections and blood collection, were performed under ketamine hydrochloride sedation above 600 g. All LN biopsies were performed under ketamine hydrochloride sedation.
Cyclosporin A treatment (Sandimmune, Sandoz ; applied by intramuscular injection) was initiated at 15 mg\kg at week 50 post-SRV-2 inoculation. Cyclosporin levels in the blood were monitored on a weekly basis and the daily doses were adjusted to maintain the level at between 100 and 200 ng\ml plasma.
SRV-2.
All six rhesus macaques used in this study (A96006, A96007, A96008, A960010, A96011 and A96012) were infected intravenously with 2 ml cell culture supernatant containing 1i10' TCID &! \ml SRV-2. The source of the virus was clone A1 of A549 cells from an M. nemestrina infected with SRV-2 . The clone was cultured in complete DMEM containing 10 % FCS. When the culture was just confluent, the medium was changed to DMEM containing 2 % FCS. Medium was collected after 48 h and concentrated tenfold on a Millipore Minitan filtration system. The medium was titrated by terminal dilution of the concentrate into Raji cell culture in a microtitre Table 1 . Animals used in the experiments described in this paper
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EGI plate. Wells containing syncytia after 5 days were scored as positive and the TCID &! was determined by the Reed-Muench calculation. The relationship between the TCID &! in Raji cells and macaques is unknown, so the macaques may have been infected with a higher titre of virus.
Virus isolation. SRV was isolated from PBMC in Raji cells as described previously (Moazed & Thouless, 1993) . Infected Raji cell cultures that had syncytial cells in them before the end of the third week of culture were dried down and fixed on glass slides. SRV infection was confirmed by immunofluorescence with hyperimmune rabbit anti-SRV-2 serum.
Antibody detection. Antibody to SRV was detected by ELISA by the technique described by Thouless et al. (1996) . The technique is based on attachment of SRV-specific serum antibodies to detergent-disrupted, gradient-purified virus attached to an ELISA microtitre plate. The macaque serum antibodies were detected by enzyme-linked anti-macaque IgG and colour was developed by addition of the enzyme substrate. An absorbance equal to or greater than 0n3 was considered positive for SRV. Antibodies to simian immunodeficiency virus (SIV) were detected by using Western blot strips with gradient-purified SIV.
Detection of SRV by PCR. DNA was isolated from macaque PBMC with a blood DNA kit (QIAgen). The primers for SRV-2 and the conditions for the assay have been described previously . The hybridization detection and confirmation steps were not used, as detection of a band of the correct size on an agarose gel correlated with virus isolation in some macaques and evidence of infection by seroconversion in the rest of the macaques.
RF inoculation.
For inoculation of rhesus macaques with RF tissue, we homogenized 1 g RF14 tissue in 10 ml PBS. This RF tissue came from a rhesus macaque experimentally infected with SIVsm at the Yerkes Primate Center. Four rhesus macaques (A96007, A 96008, A96011 and A96012 ; see also Table 1 ) were each inoculated intraperitoneally with 2n5 ml of this homogenate.
Detection of RFHVMm sequences. The presence of RFHVMm DNA in PBMC and other tissues was detected by nested PCR. Primers used were FVEGA and KVIYB (outer primers) and SPKDA and ASPDB (inner primers) (Rose et al., 1997) or NAILA (outer, 5h CAGGGGAA-CGCCATTCTCTC), GGPVA (inner, 5h CGGAGGACCGGTGCAC-TTC) and IQRPB (outer and inner primer, 5h GCGTCGATCGGA-CGTTGTATC) for pol gene sequences, and MTEDA (outer, 5h TGACAGACGCAGCAATAACT), GIYRB (outer, 5h TAACCCTGTA-GATACCTGGA), PRPVA (inner, 5h TTCCCAGACCCGTACCACTA) and VLYSB (inner, 5h GTTCAGAATATAGCACTGGC) for glycoprotein B (glyB) sequences. Crude DNA preparations for PCR were obtained from tissues or PBMC by lysis in 10 mM Tris-HCl, pH 8n3, 2 mM MgCl # , 0n01 % NP-40 followed by addition of 200 µg\ml proteinase K. Samples were incubated at 55 mC for 60 min and heatinactivated at 95 mC for 15 min. DNA from 10& cell equivalents was subjected to PCR. All PCR experiments were carried out in duplicate or triplicate for two genes on two independent tissue samples for each tissue. For sequencing of PCR products, the amplified bands were purified and cloned into the pGEM-T vector (Promega). Cloned fragments were subjected to double-stranded DNA sequencing with Sequenase (USB) according to the manufacturer's instructions.
RFHV load in tissues. Serial threefold dilutions of crude DNA preparations (one for each tissue, see above) were subjected to PCR for RFHVMm glyB (primers MTEDA and GIYRB, 50 cycles of 1 min at 94 mC, 1 min at 60 mC and 1 min at 72 mC) and for β-globin, as a measure for DNA content (primers 5h GAAGAGCCAAGGACAGGTAC and 5h CAACTTCATCCACGTTCACC, same conditions). Normalizing for the dilution end-point of the β-globin PCR result allowed us to compare relative loads of RFHVMm in these extracts.
Propagation of RFHVMm in vitro.
PBMC from macaque A96008 or A96011 were cultured in RPMI supplemented with 10 % FCS. For coculture experiments, 10( PBMC were cultured with a 50 %-confluent culture of WI-38 cells or 293 cells (obtained from ATCC) or with primary rhesus fibroblasts. To test for RFHVMm production, supernatants were clarified by spinning at 1400 r.p.m. and precipitated overnight with 0n1 vol. 5 M NaCl and 0n25 vol. 50 % PEG-8000. Virus pellets were obtained by spinning at 13 000 r.p.m. and were subjected to PCR (with PRPVA and VLYSB primers) after proteinase K treatment, as above.
Results

Evaluation of virus status
Six rhesus macaques were obtained from the ORPRC. DNA from PBMC of these animals was subjected to PCR for both pol and glyB sequences of RFHVMm, 2 weeks before inoculation with SRV-2. No signals were obtained and the animals were therefore presumed to be negative for RFHVMm at the time of inoculation. All six macaques were then inoculated with SRV-2 (intravenously with 2 ml of a suspension containing 10' TCID &! \ml). SRV status was monitored by virus culture and immunofluorescence, PCR and testing for anti-SRV-2 antibodies by ELISA. Table 2 summarizes these data : only two of the animals (A96006 and A96008) became persistently viraemic for SRV-2 and remained antibodynegative ; the other four seroconverted after initial viraemia and no SRV-2 could be detected in their PBMC by virus culture or PCR. Animal 96011 had a decreasing antibody titre (not shown) and SRV-2 could be isolated from PBMC at 53 weeks post-infection (p.i.) on foetal tonsil cells. The sensitivity of this system for SRV-2 isolation is not known but these data suggest possible late conversion of A96011 to SRV-2 viraemia.
Two weeks after SRV-2 inoculation, four animals (A96007, A96008, A96011 and A96012) were inoculated intraperitoneally with 2 ml of a suspension of RF14 tumour material in PBS. This tumour of rhesus origin has previously been shown by us to contain RFHVMm DNA (Rose et al., 1997) and this inoculation was an attempt to recover RFHVMm from this tissue. In order to assess RFHVMm infection status in these animals, PBMC DNA was regularly tested by PCR for RFHVMm sequences. The results are shown in Table 2 . Surprisingly, some of the animals tested positive for RFHVMm (retrospectively) at the time of SRV-2 inoculation, despite the fact that all were negative 2 weeks prior to that time. RFHVMm-positive PCR results were also obtained for monkey A96006, which did not receive the RF14 inoculation and was supposed to serve as a control animal in this study. These observations indicate that the animals had been exposed to RFHVMm before the start of the experiment. In order to confirm this suspicion, we cloned and sequenced the amplified RFHVMm pol sequences from these animals and found that all the sequences differed by a single shared nucleotide from the original sequence obtained from the RF14 tumour (not shown), Table 2 . Detection of RFHVMm and SRV-2 in rhesus macaques over time RFHV was detected by PCR. SRV-2 was detected by ELISA (E), virus culture (C) or PCR (P). Cyclosporin A treatment began at week 49 p.i.
* SRV-2 was isolated on foetal tonsil cells.
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confirming that the inoculation with RF14 was probably not the source of the RFHVMm infection in these animals. Initially, RFHVMm detection in all six animals was either intermittent or absent. Subsequently, three patterns of RFHVMm detection were found. Three of the animals (A96006, A96008 and A96011) were positive at almost every time-point after week 20 post-SRV-2 inoculation. These animals will be referred to hereafter as persistently viraemic. One animal (A96007) showed intermittent signs of RFHVMm viraemia, with the second such period starting around week 50, the time of the beginning of cyclosporin A treatment. Two animals (A96010 and A96012) remained negative, except for rare positive signals for animal A96012.
Since the RF14 tumour originated in an SIVsm-infected macaque, we checked the serum of all six macaques for anti-SIV antibodies. None of the animals reacted to SIV antigens prior to inoculation with SRV-2 or with RF14 homogenate. At 6 weeks after RF14 inoculation, antibodies to SIV could be detected in the serum of A96008 and A96011 only. These antibodies persisted throughout the course of the experiment (not shown).
Tissue distribution of RFHVMm
Monkey A96006 was euthanized at 24 weeks p.i. after 10 weeks of persistent RFHVMm viraemia (see also Table 2 ). The animal was perfused with PBS at the time of euthanasia, in order to remove as many lymphocytes from tissue capillaries as possible, since we knew at the time that PBMC from this animal tested positive for RFHVMm sequences and we wished to remove as many contaminating cells as possible to prevent false-positive signals. All tissues were dissected with clean, disposable scalpels to minimize cross-contamination. Two pieces, of approximately 1 mm$, were taken from each tissue and processed for PCR. PCR for RFHVMm pol and glyB was performed as described in Methods. The results are listed in Table 3 and an example gel showing results for nested and non-nested PCR reactions for different tissues is shown in Fig.  1 . In Table 3 there are three columns : positive, weak\ indeterminate and negative. Positive means that all PCRs on both tissue samples yielded the appropriate band and negative means that none of the PCRs were positive. Weak\ indeterminate means that some but not all of the PCRs for that particular tissue were positive. We explain the latter by assuming either that the virus load was low in these tissues or that some circulating lymphocytes were not removed by the perfusion procedure. The virus load in PBMC was found to be relatively low (55-fold lower than in the tongue). The impact of the presence of RFHVMm DNA in circulating lymphocytes on the reported tissue distribution is therefore expected to be small and would only affect the low-positive or weak\ indeterminate results. The positive tissues included most lymphoid organs ; most neural tissues, on the other hand, were negative for RFHVMm sequences. All tissues tested were positive for amplification of β-globin sequences, indicating that the DNA was intact and accessible for PCR. In order to quantify RFHV levels better in the different tissues, we performed end-point dilutions of the positive tissue extracts and amplified β-globin and RFHVMm glyB sequences from the diluted samples. After the results were normalized for β-globin amplification, we calculated the efficiency of RFHVMm amplification relative to β-globin. These numbers are shown in Table 3 and the tissues in the ' positive ' column are ranked according to relative RFHVMm copy number.
Clinical observations
All six animals developed recurrent slight to moderate fever. Weight gain was normal, except for animal A96008, which grew normally until 60 weeks p.i., when it began to lose weight. Weight loss between 60 weeks p.i. and death at 67 weeks p.i. was 22 % of total body weight (4n21 kg at 60 weeks p.i.). Thrombocytopenia was observed in the SIVsm-infected EHB Fig. 1 . Results of PCR screening (non-nested, with primers MTEDA and GIYRB to give a 266 bp product, and subsequently nested, as indicated by h, with primers PRPVA and VLYSB to give a 203 bp product) of tissues from A96006. M, marker lanes (100 bp ladder) ; k, negative control lanes. Numbers indicate specific tissues ; tissues (except 23 and 24) were tested in duplicate in this experiment. Tissues tested were : 1/1h, 2/2h, axillary LN ; 4/4h, ileo-caecal LN ; 5/5h, 6/6h, inguinal LN ; 7/7h, 8/8h, 9/9h, mesenteric LN ; 10/10h, submandibular LN ; 12/12h, bone marrow ; 13/13h, thymus ; 14/14h, 15/15h, spleen ; 16/16h, trachea ; 18/18h, 19/19h, lung ; 20/20h, thyroid ; 22/22h, oesophagus ; 23/23h, stomach ; 24/24h, omentum. animals A96008 (150-350 platelets\mm$, normal range 392-636\mm$) and A96011 (episodes of 250\mm$). Both of these animals also became persistently anaemic, with A96008 again more severely affected [haemoglobin level 9n1-10n5 mg\l, packed cell volume (PCV)
33 %] than A96011 (haemoglobin level 9n7-11n5 mg\l, PCV 35 %). Onset of these symptoms for A96008 was at 2-4 weeks p.i. with SRV-2 ; for animal A96011 thrombocytopenia also set in at 2-4 weeks and anaemia was not observed until 26 weeks p.i. with SRV-2. No signs of thrombocytopenia or anaemia were seen in the other four animals. Depletion of CD4 + cells, consistent with SIV infection, was observed in A96011 (down to 200 cells\mm$) and A96008 (down to 500 cells\ mm$) but not in the other animals. All other lymphocyte subset measurements were within their normal ranges.
Animal A96008 was given a 70 ml blood transfusion at 63 weeks p.i. (PCV at that time 26 %), after which its anaemia abated. It subsequently developed a large abscess (Staphylococcus) on one arm, as well as persistent diarrhoea, and was euthanized at 67 weeks p.i. Upon necropsy, all LNs were found to be markedly enlarged, consistent with generalized lymphoid hyperplasia. Animal A96011 developed persistent diarrhoea at 65 weeks p.i.
Lymphoid system
We measured the circulating levels of the pro-inflammatory cytokine interleukin-6 (IL-6) in these animals. Detectable levels of IL-6 were found frequently in the plasma of A96006, A96008 and A96011 and in the plasma of A96007 at 11 months post-SRV-2 inoculation (Fig. 2) . Circulating IL-6 therefore correlated with RFHVMm viraemia in these animals. At 11 months p.i., immediately after initiation of cyclosporin A treatment, circulating IL-6 was detectable in all animals, including A96010 and A96012.
Lymphocyte subsets were monitored during the course of the experiment. No obvious differences were found in either CD4 + T cells or CD20 + B cells between animals viraemic for EHC either RFHVMm or SRV-2 and non-viraemic animals. In animal A96011, we observed a persistent decline in CD4 + cells, consistent with SIVsm infection. Two animals that were both SIVsm-infected and persistently viraemic for RFHVMm (A96008 and A96011) had relatively high CD8 + cell counts, as did one of the RFHVMm-negative animals (A96012). An elevated level of CD8 + cells is consistent with an efficient antiviral immune response and correlates here in part with SIVsm infection. This correlation is not applicable to A96012 ; this animal had large numbers of circulating immature T cells (CD4\CD8 double-positive, constituting 5-15 % of total lymphocytes, compared with 3 % in the other five animals), indicating some other underlying immune abnormality.
Induction of RFHVMm in vitro
PBMC taken from macaque A96008 at 50 weeks p.i. were cultured in tissue culture medium without additional stimulation in the presence or absence of different target cells, including primary rhesus fibroblasts, in an attempt to transfer RFHVMm in vitro. Aliquots of culture supernatant were taken at regular intervals, cleared of cellular material and precipitated with PEG-NaCl. RFHVMm-positive signals could be detected consistently in the culture supernatant of these cultures while A96008 PBMC were present in the culture but not when they were removed, indicating that RFHVMm was produced by the PBMC and that the target cells did not become productively infected (not shown).
Discussion
We originally described RFHV sequences in paraffinembedded tissue sections of RF tissue from two macaque species (Rose et al., 1997) . The similarities between RF and KS have led researchers in the past to propose that RF in macaques could be studied as an animal model for human KS . Our finding that RFHV is closely related to HHV-8 (KS-associated herpesvirus) reinforced the similarities between these two conditions and opened up the possibility of investigating the potential aetiological role of these closely related gammaherpesviruses in the pathogenesis of these proliferative diseases. In an attempt to infect rhesus macaques experimentally with RFHVMm, we inoculated four animals of a group of six obtained from the ORPRC with homogenized tissue of a cryopreserved RF lesion from an SIVsm-infected rhesus macaque that was positive for RFHVMm sequences. Our analysis indicates that we were unsuccessful in transmitting RFHVMm to these animals but that most or all of the animals were already infected with RFHVMm. We base this conclusion on the following observations : (i) two of the animals (A96006 and A96012) tested positive for RFHVMm 2 weeks before any of the animals received the RF homogenate inoculation ; (ii) animal A96006 became persistently viraemic for RFHVMm, despite the fact that this animal did not receive the inoculum ; and (iii) all of the RFHVMm sequences retrieved from these animals were identical and differed from the input sequence. It is possible that the RF14 homogenate did in fact contain, at a low level, the variant that was subsequently found in the macaques in this study, but taken together, these arguments point strongly to the conclusion that RFHVMm was present in the animals before the start of the experiment. In fact, prior infection of these animals with RFHVMm may have precluded subsequent infection through inoculation with the RF tissue homogenate. This possibility seems likely, in view of the fact that we were successful in transmitting another virus (SIVsm) to two of the four animals through this inoculation, indicating that membranized viruses can survive prolonged freezing and subsequent homogenization.
All six animals were inoculated with SRV-2. It has been shown that SRV-2 viraemia is strongly associated with RF (Benveniste et al., 1986 ; Shiigi et al., 1986) and we reasoned that this association could be due to up-regulation or enhancement of RFHV by SRV-2. Two animals in this study became viraemic for SRV-2 (A96006 and A96008), whereas the other animals developed anti-SRV-2 antibodies and remained non-viraemic. Of those animals, A96011 became infected with SIVsm through the inoculation with RF tissue. Both of the SRV-2-viraemic animals, as well as A96011 (SIVsm infected), became persistently viraemic for RFHVMm, as demonstrated by positive PCR signals for RFHVMm sequences in PBMC DNA. The correlation between productive retrovirus infection, be it SRV-2 or SIVsm, and RFHVMm viraemia indicates that these viruses indeed interact in infected animals in vivo and that the retrovirus infection enhances RFHVMm viraemia. Both RFHVMm (this study) and the retroviruses used in this study have a wide tissue distribution and are found in PBMC (Bryant et al., 1986 ; Moazed & Thouless, 1993) , illustrating the possibility of either direct interactions or indirect interactions through production or induction of cytokines by infected cells. Alternatively, the immunodeficiency associated with infection with either one of these retroviruses could be responsible for the induction of RFHVMm viraemia. Animal A96007 showed evidence of late RFHVMm viraemia, despite the fact that it had developed antibodies to SRV-2 and was not infected with SIV. This animal therefore illustrates that RFHVMm activation in vivo is not dependent solely on productive retrovirus infection but that other factors may result in the same outcome. Since the development of RFHVMm viraemia in this animal occurred shortly after the initiation of cyclosporin A treatment, the resulting induced immunosuppression in this animal seems a likely candidate for the condition that induced the persistent RFHVMm viraemia. This finding suggests that the development of KS in humans undergoing cyclosporin A immunosuppressive therapy could also be a direct result of activation of HHV-8 and ensuing HHV-8 viraemia.
Signs of chronic immune dysfunction were detected in most animals in this study. Of these, circulating IL-6 appears EHD most specific for RFHVMm viraemia, since detection of IL-6 correlated with RFHVMm viraemia, e.g. in animal A96007, in which persistent RFHVMm viraemia and IL-6 were both detected after 11 months. Elevated IL-6 levels have been reported for animals with RF (Roodman et al., 1991) , the disease found to be associated with RFHVMn in pigtailed macaques (Rose et al., 1997) . Elevated IL-6 levels have also been found to be associated with KS in humans in some studies (de Wit et al., 1991) but not in all (Dourado et al., 1997) . IL-6 is an autocrine growth factor for KS cells in vitro (Bailer et al., 1997 ; Miles et al., 1990) , pointing to an important biological role for this cytokine in KS pathogenesis. This central role is underlined by the discovery of a functional IL-6 gene in the genome of HHV-8 (Molden et al., 1997 ; Moore et al., 1996 ; Neipel et al., 1997 ; Nicholas et al., 1997) . Our finding that elevated levels of IL-6 coincided with RFHVMm viraemia in macaques in the absence of disease suggests that the role of this cytokine in the early development of KS in vivo warrants further study.
Other than in lymphoid organs and PBMC, high RFHVMm titres were found in oral cavity tissues such as tongue and cheek, which parallels AIDS-associated KS, in that HHV-8-positive KS lesions often develop in the mouth (Di Alberti et al., 1996 , 1997 Porter & Scully, 1994) . Furthermore, HHV-8 has been detected in the saliva of HIV-1-infected individuals with and without KS (Blackbourn et al., 1998 ; Boldogh et al., 1996 ; Koelle et al., 1997 ; Vieira et al., 1997) . We also found RFHVMm in the lungs, which are frequently a site of KS development in AIDS patients, with shedding of HHV-8 detected in pulmonary fluids (Cathomas et al., 1996 ; . In KS patients, HHV-8 is found in all lymphoid organs tested (Corbellino et al., 1996) , and we report here that RFHVMm was detected in almost all lymphoid organs. In summary, the tissue distributions of RFHVMm and KSHV are very similar, which indicates a common biology between these two viruses in their respective hosts.
Our data indicate that RFHVMm is prevalent in rhesus macaques and that retrovirus infection can activate this virus. These findings suggest that the same could also be true for other macaque species. This hypothesis needs to be verified and we are currently establishing serological assays for RFHV to address this question. If indeed an RFHV variant is present in the majority of captive macaques, and has been in the past, it becomes necessary to address the potential role of RFHV in the disease symptoms classically described as being associated with both SRV and SIV infections of macaques. On the other hand, if RFHVMn was introduced into the WaRPRC colony just before 1976 (when the first RF case was diagnosed), the onset of the RF epidemic and the subsequent low incidence of RF, even in SRV-2-viraemic animals, could be explained by a slow spread of RFHV in the colony. These hypotheses are testable by screening historical sera as well as sera from wildcaught macaques for RFHVMn and these studies are currently under way.
